The global hemostats market, valued at US$ 2,744.28 million in 2023, is poised to experience significant growth over the next decade, with projections indicating a market value of US$ 4,568.90 million ...

The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...

Chandigarh [India], February 28: SeraSeal™, the world's first and only primary hemostatic agent, has been approved for use in trauma and emergency bleed management under the Nammai Kaakkum 48 ...